Invivyd, Inc. — Director's Dealing 2021

Nov 24, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adagio Therapeutics, Inc. (ADGI)
CIK: 0001832038
Period of Report: 2021-11-19

Reporting Person: Miller Redonda (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-19	Stock Option (Right to Buy)	$20.07	A	62605	Acquired	2031-11-18	Common Stock (62605)	Direct

Footnotes

F1: One third (1/3) of the option shall vest on November 19, 2022, and thereafter, the remainder of the option shall vest in 24 equal monthly installments on the 19th day of each month, subject to the Reporting Person's continuous service on each vesting date.